CSTI-300 (SMP-100); a novel 5-HT3 receptor partial agonist with potential to treat patients with irritable bowel syndrome or carcinoid syndrome
- Submitting institution
-
The University of Birmingham
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 91966941
- Type
- D - Journal article
- DOI
-
10.1124/jpet.119.261008
- Title of journal
- Journal of Pharmacology and Experimental Therapeutics
- Article number
- -
- First page
- 122
- Volume
- 373
- Issue
- 1
- ISSN
- 0022-3565
- Open access status
- Compliant
- Month of publication
- March
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
16
- Research group(s)
-
-
- Citation count
- 2
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Corresponding author AND an author who made significant contribution to the paper including making a substantial contribution to 1. conception and design of the study, 2. the organisation and conduct of the study, 3. carrying out the study, 4. analysing and interpretation of the study data, 5. helping draft the output, 6. helping critique the output for important intellectual content
- Non-English
- No
- English abstract
- -
